| Primary |
| Hypertension |
59.5% |
| Blood Pressure Increased |
19.0% |
| Cellulitis |
2.4% |
| Diabetes Mellitus |
2.4% |
| Diuretic Therapy |
2.4% |
| Oedema Peripheral |
2.4% |
| Schizophrenia, Paranoid Type |
2.4% |
| Smoking Cessation Therapy |
2.4% |
| Sodium Retention |
2.4% |
| Supraventricular Tachycardia |
2.4% |
| Vaginal Abscess |
2.4% |
|
| Hyponatraemia |
19.4% |
| Hypokalaemia |
12.9% |
| Gout |
6.5% |
| Hypotension |
6.5% |
| Renal Failure Acute |
6.5% |
| Abdominal Pain |
3.2% |
| Adrenal Adenoma |
3.2% |
| Balance Disorder |
3.2% |
| Blister |
3.2% |
| Blood Creatinine Increased |
3.2% |
| Blood Potassium Decreased |
3.2% |
| Constipation |
3.2% |
| Diarrhoea |
3.2% |
| Dysuria |
3.2% |
| Gait Disturbance |
3.2% |
| Heart Rate Decreased |
3.2% |
| Heart Rate Increased |
3.2% |
| Loss Of Control Of Legs |
3.2% |
| Medication Error |
3.2% |
| Oropharyngeal Pain |
3.2% |
|
| Secondary |
| Hypertension |
37.0% |
| Product Used For Unknown Indication |
15.2% |
| Drug Use For Unknown Indication |
6.6% |
| Essential Hypertension |
3.8% |
| Malignant Hypertension |
3.8% |
| Blood Pressure Abnormal |
3.2% |
| Heart Rate Irregular |
3.2% |
| Blood Cholesterol Increased |
2.8% |
| Fluid Retention |
2.5% |
| Osteoarthritis |
2.5% |
| Rheumatoid Arthritis |
2.5% |
| Cardiac Failure Congestive |
2.2% |
| Diabetes Mellitus |
2.2% |
| Hypotension |
2.2% |
| Cardiovascular Disorder |
1.9% |
| Cerebrovascular Accident Prophylaxis |
1.9% |
| Staphylococcal Bacteraemia |
1.9% |
| Diuretic Therapy |
1.6% |
| Prostate Cancer |
1.6% |
| Arrhythmia |
1.3% |
|
| Renal Failure |
9.4% |
| Drug Ineffective For Unapproved Indication |
7.5% |
| Urinary Tract Infection |
7.5% |
| Weight Decreased |
7.5% |
| Blindness |
5.7% |
| Drug Interaction |
5.7% |
| Syncope |
5.7% |
| Vomiting |
5.7% |
| Abdominal Pain |
3.8% |
| Decreased Appetite |
3.8% |
| Drug Hypersensitivity |
3.8% |
| Headache |
3.8% |
| Malaise |
3.8% |
| Muscle Spasms |
3.8% |
| Nausea |
3.8% |
| Pancreatitis Acute |
3.8% |
| Rash Papulosquamous |
3.8% |
| Sepsis |
3.8% |
| Thyroid Neoplasm |
3.8% |
| Urinary Retention |
3.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.8% |
| Hypertension |
24.3% |
| Drug Use For Unknown Indication |
8.5% |
| Rheumatoid Arthritis |
4.8% |
| Diabetes Mellitus |
4.4% |
| Pain |
3.0% |
| Atrial Fibrillation |
2.8% |
| Blood Pressure |
2.6% |
| Depression |
2.6% |
| Blood Cholesterol Increased |
2.5% |
| Multiple Myeloma |
2.2% |
| Osteoporosis |
2.0% |
| Chronic Obstructive Pulmonary Disease |
1.9% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Prophylaxis |
1.9% |
| Asthma |
1.7% |
| Diuretic Therapy |
1.6% |
| Nuclear Magnetic Resonance Imaging |
1.6% |
| Supplementation Therapy |
1.6% |
| Anxiety |
1.5% |
|
| Weight Decreased |
11.5% |
| Drug Ineffective |
7.9% |
| Vomiting |
7.5% |
| Death |
5.9% |
| Pain |
5.9% |
| Vision Blurred |
5.9% |
| Somnolence |
5.5% |
| Nausea |
5.1% |
| Hypertension |
4.7% |
| Thrombocytopenia |
4.3% |
| Diarrhoea |
4.0% |
| Drug Interaction |
4.0% |
| Pneumonia |
4.0% |
| Urinary Tract Infection |
4.0% |
| Dizziness |
3.6% |
| Rectal Haemorrhage |
3.6% |
| Blood Pressure Increased |
3.2% |
| International Normalised Ratio Increased |
3.2% |
| Myocardial Infarction |
3.2% |
| Pain In Extremity |
3.2% |
|
| Interacting |
| Hypertension |
31.8% |
| Drug Use For Unknown Indication |
13.6% |
| Cardiac Failure |
9.1% |
| Renal Failure Chronic |
9.1% |
| Type 2 Diabetes Mellitus |
9.1% |
| Atrial Fibrillation |
4.5% |
| Diabetes Mellitus |
4.5% |
| Liver Transplant |
4.5% |
| Off Label Use |
4.5% |
| Prophylaxis |
4.5% |
| Vaginal Abscess |
4.5% |
|
| Blood Creatinine Increased |
14.3% |
| Diabetes Mellitus |
14.3% |
| Drug Interaction |
14.3% |
| Pancreatitis Acute |
14.3% |
| Renal Failure Acute |
14.3% |
| Swollen Tongue |
14.3% |
| Syncope |
14.3% |
|
